NCT06012929View on ClinicalTrials.gov

A Study of ONC201 for Refractory Meningioma

PHASE2SuspendedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions

MeningiomaRefractory MeningiomaRelapsed Meningioma

Interventions

DRUG

ONC201

ONC201 is an oral medication given once per week

Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

Jazz Pharmaceuticals

All Listed Sponsors

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

University of Nebraska

OTHER